Viewing nowGlufa XR Sustained Release Tablet 1000mg (Metformin Hydrochloride)
Metformin Hydrochloride 1000mg
Tablet · Prescription medication
Dalim Biotech Co., Ltd.

MFDS item code 202000161 · Approved 2020.01.10 · Insurance code 664602630
Treatment of type 2 diabetes mellitus in adults
This medication is used for the treatment of adult patients with type 2 diabetes who do not achieve adequate blood glucose control with diet and exercise alone. It is particularly effective for overweight diabetes patients and can be used as monotherapy or in combination with other oral hypoglycemic agents or insulin to assist in blood glucose management. This helps to improve blood glucose levels and aids in the treatment of diabetes.
The dose should be determined individually based on the drug's efficacy and tolerability, and should not exceed the recommended maximum daily dose. - The usual initial dose is 500mg of metformin hydrochloride extended-release tablets once daily with the evening meal. - Blood glucose levels should be measured after one week to adjust the dose. Gastrointestinal adverse reactions may improve with gradual dose increases. The maximum dose is 2000mg per day. - When increasing the dose, increase it by 500mg each week. The dose may be increased to a maximum of 2000mg per day, taken with the evening meal. If glycemic control is not achieved with a maximum dose of 2000mg once daily, consider administering 1000mg twice daily; both doses should be taken with meals. - For patients already receiving metformin tablets, the initial dose of this formulation is the same as the daily dose of immediate-release metformin tablets. Switching to this formulation is not recommended for patients taking more than 2000mg per day of immediate-release metformin tablets. - At initiation of treatment and when adjusting the dose, fasting blood glucose should be measured to assess response to treatment and determine the minimum effective dose. Blood glycated hemoglobin levels should be measured approximately every 3 months. - The goal of treatment with this medicine, whether administered as monotherapy or in combination with a sulfonylurea or insulin, is to reduce fasting blood glucose and blood glycated hemoglobin levels to normal or near-normal levels using the minimum effective dose. Patients with renal impairment This medicine may be used in patients with moderate stage 3a renal impairment (creatinine clearance [CrCl] 45≤~ <60ml/min or glomerular filtration rate (GFR) 45≤~ <60 mL/min/1.73 m2) who have no other condition that may increase the risk of lactic acidosis, with the following dose adjustment. - The starting dose is 500mg or 750mg once daily. The maximum daily dose is 1000mg. Renal function should be monitored closely every 3- 6 months. If creatinine clearance or glomerular filtration rate falls below 45ml/min or 45ml/min/1.73m2, respectively, this medicine should be discontinued immediately.
This medication can rarely cause a very serious condition called lactic acidosis. Lactic acidosis occurs when there is an excessive buildup of lactic acid in the body and, if severe, can be life-threatening. Additionally, caution is needed when used with insulin or other diabetes medications due to the risk of hypoglycemia. Patients with moderate or severe renal impairment, dehydration, severe infections, or rapidly worsening cardiac function should not use this medication. Patients with acute heart failure or serious heart disease, and those who are scheduled for examinations using radiocontrast agents containing iodine, should discontinue or not use this medication. This medication should not be given to patients with allergy to its ingredients or to patients with type 1 diabetes, and those with metabolic acidosis. Patients with severe infections or trauma, who are in very poor condition, should temporarily discontinue this medication and resume after recovery. If surgery is planned, especially if eating or fluid intake is limited, this medication should be discontinued 48 hours before the surgery and should only be resumed after confirming normal kidney function post-surgery. Caution is also needed for patients with very poor nutritional status or problems with liver or adrenal function. During the course of this medication, kidney function should be regularly monitored, and it should be discontinued if kidney function deteriorates. Also, caution should be taken during irregular meals or vigorous exercise as there is a risk of hypoglycemia and lactic acidosis. Gastrointestinal symptoms (nausea, vomiting, diarrhea, etc.) may occur frequently at the beginning of treatment but often improve naturally over time. This medication can cause vitamin B12 deficiency, so it is advisable to regularly check vitamin B12 levels. During pregnancy, it may affect the fetus, so if pregnancy is planned or if the patient is pregnant, the use of this medication should be discussed with a physician. During breastfeeding, since this medication is secreted in breast milk, it should be carefully decided whether to continue breastfeeding. Elderly patients often experience decreased kidney function, so drug dosage should be adjusted, and kidney function should be monitored frequently. In case of overdose, this medication can be removed by hemodialysis. If overdose is suspected, seek medical attention immediately. This medication may interact with other drugs, so if other medications are being taken, be sure to inform a physician or pharmacist. Alcohol may increase the risk of side effects from this medication, so it's best to avoid drinking while taking it. While taking this medication, regular checks of blood glucose, kidney function, and blood tests should be performed to monitor treatment effectiveness and side effects.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture, and kept at room temperature between 1 degree and 30 degrees Celsius. Storing it this way helps maintain the medication's effectiveness over time.
White rectangular sustained-release film-coated tablet
100 tablets/bottle, 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMetformin Hydrochloride 1000mg
Tablet · Prescription medication
Dalim Biotech Co., Ltd.

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Celltrion Pharmaceuticals)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Daewoong Pharmaceutical)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Ildong Pharmaceutical Co., Ltd.)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Ilseong IS Co., Ltd.)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Kyungdong Pharmaceutical Co., Ltd.)

Metformin Hydrochloride 250mg
Tablet · Prescription medication
(Daewoong Pharmaceutical)

Metformin Hydrochloride 500mg
Tablet · Prescription medication
(Youngpoong Pharmaceutical Co., Ltd.)
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.